Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

30 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
B-Raf and C-Raf are required for melanocyte stem cell self-maintenance.
Valluet A, Druillennec S, Barbotin C, Dorard C, Monsoro-Burq AH, Larcher M, Pouponnot C, Baccarini M, Larue L, Eychène A. Valluet A, et al. Among authors: druillennec s. Cell Rep. 2012 Oct 25;2(4):774-80. doi: 10.1016/j.celrep.2012.08.020. Epub 2012 Sep 27. Cell Rep. 2012. PMID: 23022482 Free article.
Cell context reveals a dual role for Maf in oncogenesis.
Pouponnot C, Sii-Felice K, Hmitou I, Rocques N, Lecoin L, Druillennec S, Felder-Schmittbuhl MP, Eychène A. Pouponnot C, et al. Among authors: druillennec s. Oncogene. 2006 Mar 2;25(9):1299-310. doi: 10.1038/sj.onc.1209171. Oncogene. 2006. PMID: 16247450
Gene expression signature associated with BRAF mutations in human primary cutaneous melanomas.
Kannengiesser C, Spatz A, Michiels S, Eychène A, Dessen P, Lazar V, Winnepenninckx V, Lesueur F, Druillennec S, Robert C, van den Oord JJ, Sarasin A, Bressac-de Paillerets B; EORTC Melanoma group. Kannengiesser C, et al. Among authors: druillennec s. Mol Oncol. 2008 Apr;1(4):425-30. doi: 10.1016/j.molonc.2008.01.002. Epub 2008 Jan 12. Mol Oncol. 2008. PMID: 19383316 Free PMC article.
Skin tumors induced by sorafenib; paradoxic RAS-RAF pathway activation and oncogenic mutations of HRAS, TP53, and TGFBR1.
Arnault JP, Mateus C, Escudier B, Tomasic G, Wechsler J, Hollville E, Soria JC, Malka D, Sarasin A, Larcher M, André J, Kamsu-Kom N, Boussemart L, Lacroix L, Spatz A, Eggermont AM, Druillennec S, Vagner S, Eychène A, Dumaz N, Robert C. Arnault JP, et al. Among authors: druillennec s. Clin Cancer Res. 2012 Jan 1;18(1):263-72. doi: 10.1158/1078-0432.CCR-11-1344. Epub 2011 Nov 17. Clin Cancer Res. 2012. PMID: 22096025
NRAS-driven melanoma: A RAF can hide another.
Druillennec S, Pouponnot C, Eychène A. Druillennec S, et al. Mol Cell Oncol. 2017 Jul 5;4(6):e1344758. doi: 10.1080/23723556.2017.1344758. eCollection 2017. Mol Cell Oncol. 2017. PMID: 29209643 Free PMC article.
30 results